End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,840 KRW | -2.96% | +2.18% | -6.20% |
Business Summary
Number of employees: 231
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Device
94.3
%
| 112,754 | 96.7 % | 134,823 | 94.3 % | +19.57% |
Other
5.7
%
| 3,796 | 3.3 % | 8,207 | 5.7 % | +116.21% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
64.3
%
| 70,587 | 60.6 % | 92,006 | 64.3 % | +30.34% |
South Korea
19.3
%
| 17,094 | 14.7 % | 27,598 | 19.3 % | +61.44% |
America
8.2
%
| 15,801 | 13.6 % | 11,683 | 8.2 % | -26.07% |
Europe
4.7
%
| 7,318 | 6.3 % | 6,749 | 4.7 % | -7.77% |
Others
3.5
%
| 5,749 | 4.9 % | 4,994 | 3.5 % | -13.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jong-Hwan Kim
CEO | Chief Executive Officer | 56 | - |
Bo-Gun Jeong
AUD | Comptroller/Controller/Auditor | 47 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jong-Hwan Kim
CEO | Chief Executive Officer | 56 | - |
Hong-Sik Park
BRD | Director/Board Member | 46 | - |
Ji-Su Park
BRD | Director/Board Member | 52 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,637,849 | 52,943,960 ( 69.08 %) | 1,206,886 ( 1.575 %) | 69.08 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
JEISYS MEDICAL INC. 0.17% | 131,048 | 0.17% | 774,850 $ |
ILOODA CO., LTD 0.55% | 112,359 | 0.55% | 522,464 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.20% | 564M | |
+8.24% | 219B | |
+7.46% | 184B | |
+13.07% | 138B | |
-1.37% | 62.54B | |
+4.88% | 52.22B | |
+11.55% | 51.73B | |
+2.30% | 41.4B | |
+4.66% | 37.17B | |
+22.55% | 31.76B |
- Stock Market
- Equities
- A287410 Stock
- Company Jeisys Medical Inc.